Remicade, which is a drug for rheumatoid arthritis.    From Wordnik.com.  [CNN Transcript Oct 22, 2009] Reference

Remicade, which is approved for inflammatory diseases, delivered year-over-year growth of.    From Wordnik.com. Reference

After my first infusion of a second drug, called Remicade, I immediately felt a difference.    From Wordnik.com.  [News for Culpeper Star-Exponent] Reference

More surprising were uninspired showings for blockbusters such as Remicade and Risperdal.    From Wordnik.com.  [J&J Drug Sales Hurt Net but Forecast Is Raised] Reference

Infliximab is known by the brand name Remicade®.    From Wordnik.com.  [EurekAlert! - Breaking News] Reference

But the detail around Remicade makes the math a little murkier.    From Wordnik.com.  [Merck Trials an M&A Remedy] Reference

But losing out on Remicade could still leave investors feeling bruised.    From Wordnik.com.  [Merck Trials an M&A Remedy] Reference

Remicade is given as a two-hour intravenous infusion at a doctor's office.    From Wordnik.com.  [J&J Psoriasis Drug Shows Promise in Study] Reference

J would seek damages based on the revenue generated by Remicade and Simponi since J.    From Wordnik.com.  [J] Reference

These anti-TNF therapies go by names that consumers recognize as Remicade and Enbrel.    From Wordnik.com.  [The Autoimmune Epidemic] Reference

I do have some info in that area, since I have a kid with Crohn's who's taking Remicade.    From Wordnik.com.  [The Health FAQ] Reference

I've been watching my temp since then, because this can be a side effect of the Remicade.    From Wordnik.com.  [Sometimes you feel as if you are swimming upstream] Reference

The analyst attributed the year-over-year gain to sales in Nasonex, PEG-Intron and Remicade.    From Wordnik.com.  [Schering-Plough Seen Challenged By Generics in 2006] Reference

The issue centers on the anti-inflammatory drug Remicade, which J&J and Schering-Plough co-market.    From Wordnik.com.  [Deal Complicates Rights to Big Drug] Reference

Analysts view ustekinumab as a potential follow-up to J&J's existing anti-inflammatory drug, Remicade.    From Wordnik.com.  [J&J Psoriasis Drug Shows Promise in Study] Reference

Sales rose 5.5% in the latest quarter, while in the year-earlier third quarter Remicade sales were up 21%.    From Wordnik.com.  [J&J Drug Sales Hurt Net but Forecast Is Raised] Reference

Another laggard in the third quarter, the anti-inflammatory medicine Remicade, rebounded as the year ended.    From Wordnik.com.  [J&J's Net Climbs, but Patent Woes Loom] Reference

Schering-Plough holds most of the marketing rights to Remicade outside the U.S. while J&J retains those in the U.S.    From Wordnik.com.  [J&J Would End Schering Drug Rights] Reference

Remicade, for inflammatory disorders, also increased more slowly than in the past, as it faces increased competition.    From Wordnik.com.  [J&J Drug Sales Hurt Net but Forecast Is Raised] Reference

Two years ago had 95% clearing on Remicade then had a severe allergic reaction and my body could no longer tolerate the infusion.    From Wordnik.com.  [Psoriasis Guru » Blog Archive » New Psoriasis Drug from Johnson and Johnson: Stelara (Ustekinumab)] Reference

J&J sells Remicade, an anti-inflammatory drug, with Schering-Plough, and a deal for the company could give it full rights to the drug.    From Wordnik.com.  [Drug-Industry Shakeout Hits Small Firms Hard] Reference